✦ LIBER ✦

Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer

✍ Scribed by García-Alfonso, P; Muñoz-Martin, A J; Alvarez-Suarez, S; Jerez-Gilarranz, Y; Riesco-Martinez, M; Khosravi, P; Martin, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine and bevacizumab as first-li

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Reply: Capecitabine and bevacizumab as f

✍ Feliu, J; Barriuso, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Comment on ‘Capecitabine and bevacizumab

✍ Molina-Garrido, M J; Guillén-Ponce, C 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

First-line panitumumab plus irinotecan/5

✍ Claus-Henning Köhne; Ralf Hofheinz; Laurent Mineur; Henry Letocha; Richard Greil 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 584 KB

Capecitabine and mitomycin C as third-li

✍ Chong, G; Dickson, J L B; Cunningham, D; Norman, A R; Rao, S; Hill, M E; Price, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Capecitabine maintenance therapy after f

✍ Yan Li; Jing Li; Ming Lu; Xi-cheng Wang; Lin Shen 📂 Article 📅 2010 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 198 KB